Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr James Lordan

Newcastle AuthorsTitleYearFull text
Dr James Lordan
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma2025
Dr Pauline Pradere
Saskia Bos
Dr Andre Pozza
Dr Gerard Meachery
Dr James Lordan
et al.		Outcomes of listing for lung and heart–lung transplantation in pulmonary hypertension: comparative experience in France and the UK2024
Dr James Lordan
Dr Moha Shojaei
Dr Nan Lin
Professor James Wason
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies2024
Dr James Lordan
Sendaway capillary NT-proBNP in pulmonary hypertension2024
Dr James Lordan
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex2023
Dr James Lordan
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control2023
Saskia Bos
Dr James Lordan
Dr Arun Nair
Professor Andrew Fisher
Dr Gerard Meachery
Lung transplantation for interstitial lung disease: evolution over three decades2023
Dr James Lordan
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes2022
Dr James Lordan
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension2022
Dr James Lordan
Bayesian Inference Associates Rare KDR Variants with Specific Phenotypes in Pulmonary Arterial Hypertension2021
Dr James Lordan
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood2021
Dr James Lordan
Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement2021
Dr James Lordan
Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacy2021
Dr James Lordan
A European Multi-Center, Randomized, Double-Blind Trial of Pirfenidone in Bronchiolitis-Obliterans-Syndrome Grade 1-3 in Lung Transplant Recipients (European Trial of Pirfenidone in BOS (EPOS))2020
Professor Andrew Fisher
Dr James Lordan
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?2020
123